Glycogen synthase kinase-3 as a key regulator of cognitive function

Acta Biochim Biophys Sin (Shanghai). 2020 Mar 18;52(3):219-230. doi: 10.1093/abbs/gmz156.

Abstract

Glycogen synthase kinase-3 (GSK-3) is a highly conserved and multifunctional serine/threonine protein kinase widely distributed in eukaryotic cells. GSK-3 is originally thought to be an enzyme that regulates glycogen synthesis. It was subsequently found that GSK-3 influences many critical cellular functions, such as cell structure, neural plasticity, gene expression, and neuronal survival. Recently, GSK-3 has been found to be associated with cognition, and its dysregulation leads to cognitive impairments in many diseases, including Alzheimer's disease, diabetes, depression, Parkinson's disease, and others. In this review, we summarized the current knowledge about the structure of GSK-3, the regulation of GSK-3 activity, and its role in cognitive function and cognitive-related disease.

Keywords: GSK-3; cognitive function; neurogenesis; neuroinflammation; synaptic plasticity.

Publication types

  • Review

MeSH terms

  • Alzheimer Disease / physiopathology
  • Animals
  • Cognition / physiology*
  • Cognition Disorders / physiopathology
  • Glycogen Synthase Kinase 3 / metabolism*
  • Glycogen Synthase Kinase 3 / physiology*
  • Humans
  • Neuroimmunomodulation / physiology
  • Neuronal Plasticity / physiology
  • Parkinson Disease / physiopathology
  • Protein Serine-Threonine Kinases / metabolism
  • Signal Transduction / physiology
  • Structure-Activity Relationship

Substances

  • Protein Serine-Threonine Kinases
  • Glycogen Synthase Kinase 3